πŸ‡ΊπŸ‡Έ FDA
Patent

US 8128930

Anti-ADDL antibodies and uses thereof

granted A61PA61P25/00A61P25/28

Quick answer

US patent 8128930 (Anti-ADDL antibodies and uses thereof) held by Northwestern University expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P25/00, A61P25/28, A61P3/06, A61P43/00